You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for CDDO-Me
CDDO-Me is a Nrf2 pathway activator. Induces expression of Nrf-2 regulated, cytoprotective genes in vivo. Also blocks the NF-κB pathway by direct inhibition of IKKβ. Inhibits production of a wide range of inflammatory mediators in vitro.
Technical Data for CDDO-Me
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for CDDO-Me
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for CDDO-Me
The following data is based on the product molecular weight 505.69. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.5 mM||3.95 mL||19.77 mL||39.55 mL|
|2.5 mM||0.79 mL||3.95 mL||7.91 mL|
|5 mM||0.4 mL||1.98 mL||3.95 mL|
|25 mM||0.08 mL||0.4 mL||0.79 mL|
References for CDDO-Me
References are publications that support the biological activity of the product.
Ahmad et al (2006) Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179. J.Biol.Chem. 281 35764 PMID: 16998237
Yates et al (2007) Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol.Cancer Ther. 6 154 PMID: 17237276
Liby & Sporn (2012) Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol.Rev. 64 972 PMID: 22966038
If you know of a relevant reference for CDDO-Me, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: CDDO-Me, CDDO-Me supplier, CDDO, methyl, ester, bardoxolone, Nrf2, activators, activates, NF-kappaB, inhibitors, inhibits, IKKbeta, IkappaB, NF-kB/IkB, IkB, Kinase, 6646, Tocris Bioscience
Citations for CDDO-Me
Citations are publications that use Tocris products.
Currently there are no citations for CDDO-Me. Do you know of a great paper that uses CDDO-Me from Tocris? Please let us know.
Reviews for CDDO-Me
There are currently no reviews for this product. Be the first to review CDDO-Me and earn rewards!
Have you used CDDO-Me?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cancer Metabolism Research Product GuideNew
This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:
- Tricarboxylic Acid Cycle
- 1C Metabolism and Nucleic Acid Synthesis
- Drivers of Metabolic Reprogramming
- pH and Redox Balance
Cancer Metabolism Poster
This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.